---
title: "Aehr tripled its revenue in a quarter and Wall Street still cut its price targets"
description: "Aehr Test Systems tripled quarterly revenue, raised its year to $150 million and jumped 26.5% in a day, yet two analysts cut price targets into the rally and the 10-Q names the risks the multiple has to outrun."
publisher: "The Inference"
section: "Chips"
published: 2026-11-07T16:11:16.472Z
modified: 2026-11-07T16:11:16.472Z
canonical: https://theinference.org/article/aehr-tripled-its-revenue-in-a-quarter-and-wall-street-still-cut-its-price-targets
language: en
keywords: "Aehr Test Systems, Semiconductors, Earnings, Analyst Calls, Burn In Testing"
---

# Aehr tripled its revenue in a quarter and Wall Street still cut its price targets

> Aehr Test Systems tripled quarterly revenue, raised its year to $150 million and jumped 26.5% in a day, yet two analysts cut price targets into the rally and the 10-Q names the risks the multiple has to outrun.

[Aehr Test Systems](https://theinference.org/markets/companies/aehr-test-systems) of Fremont, California builds the machines that stress-test AI chips before they ship, cooking semiconductors with power and heat so the failures show up in the factory and not in a data center.

On November 2, after the close, it [printed a record quarter](https://www.marketscreener.com/news/aehr-test-reports-record-first-quarter-fiscal-2027-revenue-of-33-0-million-raises-full-year-reve-ce785fd9dd8bf425): revenue of $33.0 million, triple the $11.0 million of a year earlier and up 75% sequentially, with non-GAAP earnings of $0.28 a share against an $0.11 consensus [1][2]. The stock closed at $51.47 that day and $65.11 the next, a 26.5% jump, on a year-to-date run near 194% [1][4].

## The guide triples the year

Bookings of $46.7 million ran 40% above revenue, a book-to-bill of about 1.4, and backlog hit $100.9 million at quarter end, $109.3 million counting post-quarter orders [1]. Management raised fiscal 2027 revenue guidance to $150 million, triple fiscal 2026, and promised non-GAAP net income of at least 20% of revenue [1].

*Chart: **Revenue swung from $21.4M in 2023 to a $9.9M trough before the AI quarter** Column chart of Aehr quarterly revenue across twelve fiscal quarters*

*Quarterly revenue in $ millions, fiscal quarters labeled by calendar quarter. Source: Aehr Test Systems quarterly figures from SEC filings, via company_series [10]. [10]*

The demand story is concrete: more than a dozen Sonoma burn-in systems a month for a lead hyperscale customer's first AI processor, a second processor already qualified for a 2027 ramp, and a new wafer-level burn-in cell headed for a Taiwan assembly partner in early 2027 that the chief executive calls [one of the largest opportunities Aehr has ever pursued](https://www.tradingview.com/news/benzinga:41650c51a094b:0-aehr-stock-surges-as-ceo-says-ai-chip-complexity-is-accelerating-burn-in-demand/) [1][2].

## Wall Street cut its targets into the pop

Here is the complication. Lake Street [kept its Buy and dropped its target to $90 from $110](https://www.tradingview.com/news/tradingview:7f06bd0c4824b:0-lake-street-maintains-aehr-test-system-at-buy-lowers-price-target-to-90-from-110/), citing valuation compression across semiconductor equipment, and [Jefferies](https://theinference.org/markets/companies/jefferies) went to $140 from $175 on the same logic [3][8]. The stock trades near 42.5 times sales while trailing free cash flow sits around negative $5.5 million [4].

*Chart: **Both targets came down, but sit far above the $65.11 close** Column chart of Lake Street and Jefferies price targets on Aehr before and after the quarter*

*Analyst price targets on Aehr Test Systems before and after the November 2 print, in dollars, against the $65.11 close of November 3. Sources: Lake Street via TradingView [3]; Stocktwits News via Yahoo Finance [8]. [3][8]*

The order book says triple; the cash flow statement has not been told yet. Cash on hand is $105.1 million [1], and Jefferies notes backlog already covers most of the new fiscal year [8].

## Concentration is the fault line

[The 10-Q filed November 6](https://www.tradingview.com/news/urn:summary_document_report:quartr.com:4497902:0-aehr-ai-demand-drove-201-revenue-growth-and-a-return-to-quarterly-profitability/) lists shipment timing, customer concentration, tariffs and patent litigation as the key uncertainties [5]. Simply Wall St's bear case prices the stock 256% overvalued on insider selling and dilution, the same selling this publication [reported in October](https://theinference.org/article/aehr-test-systems-insiders-sold-62-5-million-and-bought-nothing-as-the-stock-fell-32-3-in-a-month), against a bull case 41% undervalued [4][9].

Retail holders on [Stocktwits](https://stocktwits.com/ceonner/message/668012040) are waiting for $110 [7]. One position has quietly changed hands: [Jane Street](https://theinference.org/markets/companies/jane-street) [filed a 13G/A on November 6](https://www.sec.gov/Archives/edgar/data/1040470/000159588826000126/0001595888-26-000126-index.htm) showing a 3.3% stake, 1,076,577 shares, held with no sole voting power, the footprint of a trading book rather than an owner [6].

## What decides it next

Two dated events settle the argument. A high-volume production decision from the Taiwan evaluation, expected within months of the early-2027 installation, tells whether the wafer-level business is one customer or a market [1]. The second AI processor's calendar-2027 ramp tells whether the dozen-systems-a-month pace holds or doubles [1][2]. Between now and then, watch the backlog convert: at $65 a share the market has already spent the $150 million, and only shipped boxes can pay for it [1][2].

## Takeaway

Aehr tripled revenue and tripled its year-ahead guide, yet analysts cut targets on a 42.5x sales multiple, negative trailing free cash flow and a 10-Q that names concentration risk; backlog conversion is what has to pay for the rally.

## Sources

1. [MarketScreener / Aehr Test Systems press release, Record First Quarter Fiscal 2027 Revenue of $33.0 Million, 2 November 2026](https://www.marketscreener.com/news/aehr-test-reports-record-first-quarter-fiscal-2027-revenue-of-33-0-million-raises-full-year-reve-ce785fd9dd8bf425)
2. [Benzinga via TradingView, Aehr Stock Surges As CEO Says AI Chip Complexity Is Accelerating Burn-In Demand, 3 November 2026](https://www.tradingview.com/news/benzinga:41650c51a094b:0-aehr-stock-surges-as-ceo-says-ai-chip-complexity-is-accelerating-burn-in-demand/)
3. [TradingView, Lake Street maintains Aehr Test System at Buy, lowers price target to $90 from $110, 4 November 2026](https://www.tradingview.com/news/tradingview:7f06bd0c4824b:0-lake-street-maintains-aehr-test-system-at-buy-lowers-price-target-to-90-from-110/)
4. [Yahoo Finance / Simply Wall St, Is Aehr Test Systems (AEHR) Priced For Perfection After 194% Run?, 4 November 2026](https://sg.finance.yahoo.com/news/aehr-test-systems-aehr-priced-190834773.html)
5. [Quartr summary of Aehr Test Systems 10-Q via TradingView, 6 November 2026 filing](https://www.tradingview.com/news/urn:summary_document_report:quartr.com:4497902:0-aehr-ai-demand-drove-201-revenue-growth-and-a-return-to-quarterly-profitability/)
6. [SEC Schedule 13G/A, Jane Street Group LLC re Aehr Test Systems, filed 6 November 2026](https://www.sec.gov/Archives/edgar/data/1040470/000159588826000126/0001595888-26-000126-index.htm)
7. [Stocktwits, @ceonner on $AEHR, collected 4 November 2026](https://stocktwits.com/ceonner/message/668012040)
8. [Stocktwits News via Yahoo Finance, AEHR Stock Heads For Biggest Single-Day Gain Since July, Analysts Cut Targets Despite Earnings Beat, 3 November 2026](https://finance.yahoo.com/markets/stocks/articles/aehr-stock-heads-biggest-single-154700013.html)
9. [The Inference, Aehr Test Systems insiders sold $62.5 million and bought nothing as the stock fell 32.3% in a month, 22 October 2026](/article/aehr-test-systems-insiders-sold-62-5-million-and-bought-nothing-as-the-stock-fell-32-3-in-a-month)
10. [Aehr Test Systems quarterly figures from SEC filings, via company_series, retrieved 7 November 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001040470)


---

Aehr tripled its revenue in a quarter and Wall Street still cut its price targets — The Inference. Canonical: https://theinference.org/article/aehr-tripled-its-revenue-in-a-quarter-and-wall-street-still-cut-its-price-targets